Investigation of hallucinogenic and related beta-carbolines.
B Grella, M Dukat, R Young, Milt Teitler, K Herrick-Davis, C B Gauthier, Richard A Glennon
Drug and Alcohol Dependence April 1, 1998 DOI: 10.1016/s0376-8716(97)00163-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical laboratory study (receptor binding assay and drug discrimination experiment) Peer reviewed |
|---|---|
| Sample size | 6 |
| Population | Rats |
| Interventions | Harmaline DOM |
| Dose | 3.0 mg/kg harmaline (i.p.); 1.25 mg/kg DOM |
| Key findings | Beta-carbolines bound rat 5-HT2A and 5-HT2C receptors with affinities from about 100 nM to greater than 10,000 nM, depending on pyridyl ring saturation and methoxy substitution. In rats trained to discriminate harmaline (3.0 mg/kg) from vehicle, DOM produced 76% harmaline-appropriate responding at 1.25 mg/kg, with disruption at a higher dose. The authors conclude there is some similarity between harmaline and DOM stimulus effects. |
Abstract
Certain beta-carbolines are known to be hallucinogenic in humans, and several produce stimulus effects in animals similar to those of the classical hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM). Classical hallucinogens bind at 5-HT2 serotonin receptors and these receptors are thought to play a role in their mechanism of action. In the present study, we examined the binding of 15 beta-carbolines at rat 5-HT2A and 5-HT2C receptors. Affinities (Ki values) of the beta-carbolines ranged from about 100 nM to greater than 10,000 nM depending upon the degree of saturation of the pyridyl ring, and upon the presence and location of methoxy substituents in the benzenoid ring. In a further study, six rats were trained to discriminate the hallucinogenic beta-carboline harmaline (3.0 mg/kg, i.p.) from vehicle using a VI-15s schedule of reinforcement. This represents the first time a hallucinogenic beta-carboline has been used as a training drug in a drug discrimination study. Administration of DOM to the harmaline-trained animals resulted in 76% harmaline-appropriate responding at 1.25 mg/kg DOM and disruption of behavior at a higher dose. Taken together, the results of the present investigation demonstrate that: (a) certain beta-carbolines bind at 5-HT2 receptors; (b) that harmaline serves as a training drug at 3.0 mg/kg in drug discrimination studies with rats as subjects; and that (c) there is some similarity between the stimulus effects produced by harmaline and DOM.
Citations in the library
Cited by 30
- Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics May 1, 2004
- Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness Current Neuropharmacology March 2, 2018
- Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies Brazilian Journal of Psychiatry March 1, 2016
- Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment Progress in Neuro-Psychopharmacology and Biological Psychiatry June 10, 2012
- Acute Biphasic Effects of Ayahuasca PLoS One September 30, 2015
and 25 more in the library
Cites 4
- Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil The Journal of Nervous and Mental Disease February 1, 1996
- PSYCHOTOMIMETICS, CLINICAL AND THEORETICAL CONSIDERATIONS: HARMINE, WIN-2299 AND NALLINE American Journal of Psychiatry April 1, 1957
- Hallucinogenic plant use and related indigenous belief systems in the Ecuadorian Amazon. Journal of Ethnopharmacology April 1, 1979
- Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines. Pharmacology, Biochemistry, and Behavior October 1982